Conjunctival mucosa-associated lymphoid tissue (MALT) lymphomas are localized low-grade extra-nodal tumours that are managed with radiotherapy, cryotherapy, surgical excision, or even observation. A ...
Intergroup ALFA/GOELAMS randomized phase II trial of lirilumab anti-KIR monoclonal antibody (IPH2102/BMS986015) as maintenance treatment in elderly patients with acute myeloid leukemia (EFFIKIR trial) ...
Please provide your email address to receive an email when new articles are posted on . Upon its discovery in 1989, the only treatment for hepatitis C was interferon. Later, ribavirin was added, and ...
HAVANA—Communist-run Cuba, laboring under a six-decade U.S. embargo, is betting a biotech sector begun by late revolutionary leader Fidel Castro can give the Caribbean island an edge in a global race ...
PHILADELPHIA, Dec. 20, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that the Company has entered into an agreement with GP Pharm ...
BOSTON (AP) _ Quick treatment after infection can almost always cure hepatitis C, a condition that causes between 8,000 and 10,000 deaths in the United States each year, according to a study released ...
Intarcia Raises $50 Million in a Series BB Financing EMERYVILLE, Calif. -- Intarcia Therapeutics, Inc., a privately held biopharmaceutical company, announced the completion of a transaction to raise ...
Interferon-Free Treatment: No Longer a Dream? Several studies were presented at both Digestive Disease Week (DDW) 2012 in May and at the European Association for the Study of the Liver (EASL) annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback